Avecho Biotechnology Ltd
ASX:AVE

Watchlist Manager
Avecho Biotechnology Ltd Logo
Avecho Biotechnology Ltd
ASX:AVE
Watchlist
Price: 0.009 AUD -5.26% Market Closed
Market Cap: 33.1m AUD

Wall Street
Price Targets

AVE Price Targets Summary
Avecho Biotechnology Ltd

There are no price targets for AVE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Avecho Biotechnology Ltd Competitors:
Price Targets
326030
SK Biopharmaceuticals Co Ltd
18% Upside
600993
Mayinglong Pharmaceutical Group Co Ltd
38% Upside
1789
ScinoPharm Taiwan Ltd
28% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
42% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
13% Upside
605507
Guobang Pharma Ltd
17% Upside
TLRY
Tilray Brands Inc
90% Upside
ANCR
Animalcare Group PLC
39% Upside

Revenue
Forecast

Revenue Estimate
Avecho Biotechnology Ltd

For the last 13 years the compound annual growth rate for Avecho Biotechnology Ltd's revenue is -8%. The projected CAGR for the next 11 years is 5%.

-8%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Avecho Biotechnology Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Avecho Biotechnology Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVE's stock price target?
Not Available

AVE doesn't have any price targets made by Wall Street professionals.

What is Avecho Biotechnology Ltd's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Avecho Biotechnology Ltd's revenue is -8%. The projected CAGR for the next 11 years is 5%.

Back to Top